Open-label, single-center, randamized and parallel-group study to compare the effect of hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP) and that of fluticasone propionate dry powder inhaler (FP-DPI) on large and small airways involvement in bronchial asthma.
Phase 4
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000000983
- Lead Sponsor
- Kyoto University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1 Current smokers 2 Past treatment with inhaled corticosteroids ever 3 Past treatment with oral corticosteroids in the previous 2 months 4 Intractable infection such as systemic fungal infection 5 Allergy to the drugs used in this study 6 Tuberculosis or other respiratory infection 7 Obstructive lung disease such as COPD or bronchiectasis 8 Adrenal insufficiency 9 Dependency on systemic steroids 10 Glaucoma or cataract 11 Pregnancy or lactation 12 Inappropriate patients from the doctor's viewpoint
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method